Caribou Biosciences (CRBU) Long-Term Investments (2020 - 2026)

Caribou Biosciences (CRBU) has reported Long-Term Investments for 7 consecutive years, with $1.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Long-Term Investments fell 89.2% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (down 89.2% YoY), while the FY2025 annual figure was $3.5 million, down 62.21% from the prior year.
• Long-Term Investments eased to $1.0 million in Q1 2026 per CRBU's latest filing, from $3.5 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $69.4 million in Q4 2022 and bottomed at $132000.0 in Q2 2025.
• Historically, Long-Term Investments has averaged $23.5 million across 5 years, with a median of $9.3 million in 2024.
• Annual changes were most pronounced in 2022 — Long-Term Investments surged 809.69% — and 2025, when it tumbled 99.73%.
• Caribou Biosciences' Long-Term Investments stood at $69.4 million in 2022, then sank by 37.18% to $43.6 million in 2023, then sank by 78.71% to $9.3 million in 2024, then slumped by 62.21% to $3.5 million in 2025, then plunged by 71.44% to $1.0 million in 2026.
• Business Quant data shows CRBU's Long-Term Investments at $1.0 million in Q1 2026, $3.5 million in Q4 2025, and $143000.0 in Q3 2025.